Vimarsana
Biggest News Aggregation in the World

Page 6 - Rhinitis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rhinitis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rhinitis Today - Breaking & Trending Today

Neurent Medical: New Data show NEUROMARK Chronic Rhinitis Treatment Offers Significant Symptom Improvements - Vimarsana News

Neurent Medical: New Data show NEUROMARK Chronic Rhinitis Treatment Offers Significant Symptom Improvements

Results from the CLARITY Study Show the NEUROMARK® System Provides Safe and Effective Treatment for Patients with Chronic Rhinitis Neurent Medical, a company pioneering innovative non-surgical interventions

No increased risk of neuropsychiatric events in children born to mothers using leukotriene-receptor antagonists in pregnancy - Vimarsana News

No increased risk of neuropsychiatric events in children born to mothers using leukotriene-receptor antagonists in pregnancy

A new study examined the associations between leukotriene-receptor antagonists (LTRAs) use in pregnancy and neuropsychiatric events (NEs) risk in the offspring.

Global Allergy Diagnostics Market Report 2023: Featuring - Vimarsana News

Global Allergy Diagnostics Market Report 2023: Featuring

Dublin, March 08, 2023 (GLOBE NEWSWIRE) -- The "Allergy Diagnostics Global Market Report 2023" report has been added to ResearchAndMarkets.com's...

People with atopy have lower prevalence of cancers in extracutaneous sites and reduced melanoma risk - Vimarsana News

People with atopy have lower prevalence of cancers in extracutaneous sites and reduced melanoma risk

Fewer cases of melanoma were observed in people with a history of atopic diseases, such as allergic asthma or rhinitis, than in nonatopic people.

Allergic Rhinitis Treatment Market to Surpass US$ 20,595.6 Million by 2030, Says Coherent Market Insights (CMI) - Vimarsana News

Allergic Rhinitis Treatment Market to Surpass US$ 20,595.6 Million by 2030, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the global allergic rhinitis treatment market is estimated to be valued at US$ 14,916.9 million in 2022 and is expected